Document is current
Any future updates will be listed below
-
Authors
Wang, Haiyin
Fawsitt, Christopher G.
Orishaba, Philip
Thom, Howard
Paracha, Noman
Xue, Ruiqi
Zhang, Yuzhe
Xing, Nianzeng
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 7 October 2025
First Online: 13 November 2025
Declarations
:
: Financial interests: HT owns shares in the consulting company Clifton Insight, and PO and CF are employees of Clifton Insight, which has received fees from Amicus, Baxter, Bayer, Daiichi-Sankyo, Eisai, Lundbeck, Merck, Novo Nordisk, Pfizer, Roche, and UCB. RX and YZ are employees of the Bayer Healthcare Company Ltd. Non-financial interests: HW and NX declare that they have no conflict of interests. All the remaining authors declare no conflict of interest.
